Filing Details
- Accession Number:
- 0001567619-22-021792
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-19 16:19:26
- Reporting Period:
- 2022-12-15
- Accepted Time:
- 2022-12-19 16:19:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1623715 | Imago Biosciences Inc. | IMGO | Pharmaceutical Preparations (2834) | 454915810 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861060 | Jennifer Peppe | C/O Imago Biosciences, Inc. 329 Oyster Point Blvd, 3Rd Floor South San Francisco CA 94080 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-15 | 28,317 | $2.10 | 177,126 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-15 | 12,400 | $4.20 | 189,526 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-15 | 58,551 | $2.52 | 248,077 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-15 | 8,009 | $1.52 | 256,086 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-15 | 10,000 | $22.76 | 266,086 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-15 | 2,145 | $15.45 | 268,231 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-15 | 119,422 | $35.80 | 148,809 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2022-12-15 | 28,317 | $0.00 | 28,317 | $2.10 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2022-12-15 | 12,400 | $0.00 | 12,400 | $4.20 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2022-12-15 | 58,551 | $0.00 | 58,551 | $2.52 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2022-12-15 | 8,009 | $0.00 | 8,009 | $1.52 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2022-12-15 | 10,000 | $0.00 | 10,000 | $22.76 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2022-12-15 | 2,145 | $0.00 | 2,145 | $15.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 23,562 | 2030-09-09 | No | 4 | M | Direct | |
| 11,409 | 2031-02-04 | No | 4 | M | Direct | |
| 0 | 2021-01-01 | 2027-03-28 | No | 4 | M | Direct |
| 2,729 | 2029-04-09 | No | 4 | M | Direct | |
| 81,500 | 2031-11-16 | No | 4 | M | Direct | |
| 100,855 | 2032-11-07 | No | 4 | M | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $35.77 to $35.855, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- The Option vests with respect to 25% of the shares subject thereto on July 7, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 12, 2020 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from April 10, 2019 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
- 25% of the shares subject to the option vest on the first anniversary measured from November 17, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 8, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Billionaire Hedge Funds
